These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10865087)

  • 1. Visual pathway abnormalities Wilson's disease: an electrophysiological study using electroretinography and visual evoked potentials.
    Satishchandra P; Ravishankar Naik K
    J Neurol Sci; 2000 May; 176(1):13-20. PubMed ID: 10865087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography and electrophysiology of retinal and visual pathways in Wilson's disease.
    Langwińska-Wośko E; Litwin T; Szulborski K; Członkowska A
    Metab Brain Dis; 2016 Apr; 31(2):405-15. PubMed ID: 26686677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Wilson's disease. Presentation of a case with special reference to the study of evoked visual potentials].
    Marietti G; Pantanella P; Chiaretti A; Parenti D; Stabile A; Falsini B
    Minerva Pediatr; 1990 Nov; 42(11):489-93. PubMed ID: 2082176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Visually evoked potentials in Wilson's disease].
    Hamann KU; Hellner KA; Müller-Jensen A; Zschocke S
    Fortschr Ophthalmol; 1985; 82(2):194-6. PubMed ID: 4007736
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study on anisometropic amblyopia by simultaneously recording multifocal VEP and multifocal ERG].
    Feng LX; Zhao KX
    Zhonghua Yan Ke Za Zhi; 2005 Jan; 41(1):41-6. PubMed ID: 15774113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
    Sinha S; Taly AB
    J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-penicillamine versus zinc sulfate as first-line therapy for Wilson's disease.
    Członkowska A; Litwin T; Karliński M; Dziezyc K; Chabik G; Czerska M
    Eur J Neurol; 2014 Apr; 21(4):599-606. PubMed ID: 24447648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed evaluation of evoked potentials in Wilson's disease.
    Grimm G; Madl C; Katzenschlager R; Oder W; Ferenci P; Gangl A
    Electroencephalogr Clin Neurophysiol; 1992 Feb; 82(2):119-24. PubMed ID: 1370780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of cortical excitability and central motor conduction time in Wilson's disease.
    Jhunjhunwala K; Prashanth DK; Netravathi M; Nagaraju BC; Pal PK
    Neurosci Lett; 2013 Oct; 553():90-4. PubMed ID: 23973307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of multi-modality evoked potentials in Wilson's disease.
    Arendt G; Hefter H; Stremmel W; Strohmeyer G
    Electromyogr Clin Neurophysiol; 1994; 34(3):137-48. PubMed ID: 8045245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM
    QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
    Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
    J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evoked potentials in patients with non-neurological Wilson's disease.
    Aiello I; Sau GF; Cacciotto R; Puliga MV; Lentinu ME; Muzzu S; Posadinu D; Traccis S
    J Neurol; 1992 Feb; 239(2):65-8. PubMed ID: 1552305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
    Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute recurrent hemolytic anemia as the first manifestation of Wilson's disease: Report of a case].
    El Khattabi A; Seddik H; Fatihi J; Salaheddine H; Badaoui M; Amézyane T; Mahassine F; Ohayon V
    Transfus Clin Biol; 2009 Mar; 16(1):39-42. PubMed ID: 19329346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensory evoked potentials in Wilson's disease.
    Chu NS
    Brain; 1986 Jun; 109 ( Pt 3)():491-507. PubMed ID: 3719287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients.
    Dzieżyc K; Karliński M; Litwin T; Członkowska A
    Eur J Neurol; 2014 Feb; 21(2):332-7. PubMed ID: 24313946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual and brain stem auditory evoked responses in Wilson's disease.
    Satishchandra P; Swamy HS
    Acta Neurol Scand; 1989 Feb; 79(2):108-13. PubMed ID: 2711817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.